Page 2856 - Markets News

Nobel laureate economist recommends 'SeLFIE' solution for infra funding

Deferred-coupon debt instruments could help address asset-liability mismatch

Derivatives strategies: Strong resistance at 10,700-10,800 for Nifty

Retail investors have been direct equity sellers, but they continued to subscribe to equity mutual funds and this has been a saving grace

Centre may undershoot disinvestment target by 20%, says Macquarie

Macquarie observed that the government would have to rely on big-ticket share sales in companies such as Coal India, ONGC, Axis Bank and ITC to shore up the disinvestment kitty

Emerging market bulls starting to overtake the bears, says survey

Latin America eclipsed Eastern Europe, the Middle East and Africa as the region with the best prospects for currencies and bonds

IndusInd Bank: Q2 net grows just 5% as IL&FS worries spook Street

Due to contingency provision related to loans to IL&FS, Q2 net profit grew at the slowest pace of 5% in 42 quarters

Rupee slumps 26 paise to 73.83 against US dollar on rising crude prices

At the Forex exchange, the rupee opened lower at 73.80 and lost further ground to hit an intra-day low of 74.07 against the US dollar

Q2 preview: Infosys may see de-rating if guidance is not revised up

At the bourses, Infosys has surged 33 per cent on year-to-date (YTD) basis, as against S&P BSE Sensex's 2 per cent rise.

Top trading calls by Anand Rathi: Buy Bajaj Finance, Sun Pharma

Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT -Assistant Vice President - Equity Research, Anand Rathi Research.

MARKETS WRAP: Sensex rises 132 pts, Nifty reclaims 10,500; IT, pharma gain

Catch all the live market action

Should you buy HUL after Q2 numbers? Here's what brokerages say

The FMCG major posted a 10 per cent volume growth during the quarter, compared with 12 per cent growth in the immediately preceding quarter and four per cent a year ago.

Sebi likely to order forensic audit on half a dozen listed companies

An unusual trading pattern has been detected in shares of these firms

Midcap IT shares surge; LTTS, Aptech, Mphasis, RS Software rally up to 20%

L&T Technology Services soared 11% to Rs 1,635 on Monday, extending its Friday's 7% gain on the BSE.

Avenue Supermarts falls 7% after margin disappointment

Avenue Supermarts, which runs the D-Mart supermarkets chain, has dipped 7% to Rs 1,318 after the company's EBITDA margin declined 110 basis points at 8.0% in Q2FY19 as compared to 9.1% in Q2FY18.

IndusInd Bank Q2 profit rises 4.6% to Rs 9.2 bn on higher interest income

Gross bad loans as a percentage of total loans stood at 1.09 per cent at end-September

Short-term outlook for market looks positive; Buy Pidilite, Powergrid

The short-term outlook for the market remains negative till Nifty trades above 10,138 levels and expecting targets in the range of 1,080-11,100 levels in short term.

Investment strategies in current market

The need of the hour, analysts say, is to take stock of the situation logically and then plan your investments based on how much risk one is willing to take.

Sugar stocks extend rally; Uttam Sugar, Dwarikesh jump over 40% in one week

Thiru Arooran Sugars, Dwarikesh Sugar Industries, Uttam Sugar Mills, Dalmia Bharat Sugar and Industries and Ponni Sugars (Erode) were up in the range of 14% to 20% on Monday.

Rupee makes sharp U-turn, opens 23 paise lower against dollar

The Indian rupee has been on a downhill slide for most of the year, falling for six straight months, the longest stretch since 2002.

Q2FY19 Preview: Speed bumps ahead for the auto sector

Most of the auto stocks over the past month has corrected significantly and is off their peak valuations

Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%

Nifty Pharma index, the largest gainer among sectoral indices, was up 1.7% as compared to 0.17% decline in Nifty 50 index at 09:36 am.